The institute will focus on developing and implementing clinical practice guidelines, performance benchmarks and enhancing the partnerships that exist across McLaren facilities.
Samer Kazziha, MD, an interventional cardiologist, will leave the institute as its chief medical director.
Dr. Kazziha most recently served as the president of diagnostic and interventional cardiology for Cardiovascular Consultants, overseeing and standardizing clinical operations.